JP2022539342A5 - - Google Patents
Info
- Publication number
- JP2022539342A5 JP2022539342A5 JP2021576883A JP2021576883A JP2022539342A5 JP 2022539342 A5 JP2022539342 A5 JP 2022539342A5 JP 2021576883 A JP2021576883 A JP 2021576883A JP 2021576883 A JP2021576883 A JP 2021576883A JP 2022539342 A5 JP2022539342 A5 JP 2022539342A5
- Authority
- JP
- Japan
- Prior art keywords
- crystalline form
- compound
- approximately
- solid crystalline
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025001914A JP7858096B2 (ja) | 2019-06-24 | 2025-01-06 | tert-ブチル(S)-2-((2S,3R)-1-アミノ-3-ヒドロキシ-1-オキソブタン-2-イル)-1-オキソ-2,5-ジアザスピロ[3.4]オクタン-5-カルボキシレートの固体形態およびそれらを調製する方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962865826P | 2019-06-24 | 2019-06-24 | |
| US62/865,826 | 2019-06-24 | ||
| PCT/US2020/039163 WO2020263847A1 (en) | 2019-06-24 | 2020-06-23 | Solid forms of tert-butyl (s)-2-((2s,3r) -1-amino-3-hydroxy-1-oxobu tan-2-yl)-1-oxo-2, 5-diazaspiro [3.4] octan e-5-carboxylate and methods of preparing them |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025001914A Division JP7858096B2 (ja) | 2019-06-24 | 2025-01-06 | tert-ブチル(S)-2-((2S,3R)-1-アミノ-3-ヒドロキシ-1-オキソブタン-2-イル)-1-オキソ-2,5-ジアザスピロ[3.4]オクタン-5-カルボキシレートの固体形態およびそれらを調製する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022539342A JP2022539342A (ja) | 2022-09-08 |
| JP2022539342A5 true JP2022539342A5 (cg-RX-API-DMAC7.html) | 2023-06-30 |
| JP7617043B2 JP7617043B2 (ja) | 2025-01-17 |
Family
ID=74060350
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021576883A Active JP7617043B2 (ja) | 2019-06-24 | 2020-06-23 | tert-ブチル(S)-2-((2S,3R)-1-アミノ-3-ヒドロキシ-1-オキソブタン-2-イル)-1-オキソ-2,5-ジアザスピロ[3.4]オクタン-5-カルボキシレートの固体形態およびそれらを調製する方法 |
| JP2025001914A Active JP7858096B2 (ja) | 2019-06-24 | 2025-01-06 | tert-ブチル(S)-2-((2S,3R)-1-アミノ-3-ヒドロキシ-1-オキソブタン-2-イル)-1-オキソ-2,5-ジアザスピロ[3.4]オクタン-5-カルボキシレートの固体形態およびそれらを調製する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025001914A Active JP7858096B2 (ja) | 2019-06-24 | 2025-01-06 | tert-ブチル(S)-2-((2S,3R)-1-アミノ-3-ヒドロキシ-1-オキソブタン-2-イル)-1-オキソ-2,5-ジアザスピロ[3.4]オクタン-5-カルボキシレートの固体形態およびそれらを調製する方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220267341A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3986399A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7617043B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR20260061467A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114364380A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020304001B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021026380A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3144600A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL289198A (cg-RX-API-DMAC7.html) |
| MA (1) | MA56550A (cg-RX-API-DMAC7.html) |
| MX (2) | MX2022000069A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020263847A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI887245B (zh) * | 2019-06-24 | 2025-06-21 | 美商諾雷克斯股份有限公司 | 用於產生二氮雜螺內醯胺化合物之方法及中間物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0323204D0 (en) * | 2003-10-03 | 2003-11-05 | Novartis Ag | Organic compounds |
| ES2416354T3 (es) * | 2005-06-21 | 2013-07-31 | Ajinomoto Co., Inc. | Cristal de derivado de fenilalanina, método de producción del mismo y uso del mismo |
| MX2011003015A (es) * | 2008-09-18 | 2011-11-18 | Univ Northwestern | Moduladores del receptor de n-metil-d-aspartato, y usos de los mismos. |
| JP6419087B2 (ja) * | 2013-01-29 | 2018-11-07 | アプティニックス インコーポレイテッド | スピロラクタム系nmda受容体モジュレーターおよびその使用 |
| CA2898861C (en) * | 2013-01-29 | 2021-07-20 | Naurex, Inc. | Spiro-lactam nmda receptor modulators and uses thereof |
| TWI738748B (zh) * | 2016-03-28 | 2021-09-11 | 日商武田藥品工業有限公司 | 2-[(2s)-1-氮雜雙環[2.2.2]辛-2-基]-6-(3-甲基-1h-吡唑-4-基)噻吩并[3,2-d]嘧啶-4(3h)-酮半水合物之晶形 |
| PE20190174A1 (es) * | 2016-05-19 | 2019-02-01 | Aptinyx Inc | Moduladores del receptor espiro-lactama n-metil-d-aspartato y usos de los mismos |
| TWI887245B (zh) * | 2019-06-24 | 2025-06-21 | 美商諾雷克斯股份有限公司 | 用於產生二氮雜螺內醯胺化合物之方法及中間物 |
-
2020
- 2020-06-23 BR BR112021026380A patent/BR112021026380A2/pt unknown
- 2020-06-23 EP EP20832010.1A patent/EP3986399A4/en active Pending
- 2020-06-23 JP JP2021576883A patent/JP7617043B2/ja active Active
- 2020-06-23 MA MA056550A patent/MA56550A/fr unknown
- 2020-06-23 US US17/621,907 patent/US20220267341A1/en active Pending
- 2020-06-23 KR KR1020267012575A patent/KR20260061467A/ko active Pending
- 2020-06-23 CN CN202080059974.0A patent/CN114364380A/zh active Pending
- 2020-06-23 MX MX2022000069A patent/MX2022000069A/es unknown
- 2020-06-23 WO PCT/US2020/039163 patent/WO2020263847A1/en not_active Ceased
- 2020-06-23 AU AU2020304001A patent/AU2020304001B2/en active Active
- 2020-06-23 KR KR1020227002351A patent/KR102958083B1/ko active Active
- 2020-06-23 CA CA3144600A patent/CA3144600A1/en active Pending
-
2021
- 2021-12-21 IL IL289198A patent/IL289198A/en unknown
-
2022
- 2022-01-03 MX MX2025002579A patent/MX2025002579A/es unknown
-
2025
- 2025-01-06 JP JP2025001914A patent/JP7858096B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023511105A5 (cg-RX-API-DMAC7.html) | ||
| JP2023528450A5 (cg-RX-API-DMAC7.html) | ||
| JP2006511588A5 (cg-RX-API-DMAC7.html) | ||
| JP2017518355A5 (cg-RX-API-DMAC7.html) | ||
| JP2013541592A5 (cg-RX-API-DMAC7.html) | ||
| CN1443168A (zh) | 纯晶形的5-氯-3-(4-甲磺酰基苯基)-6′-甲基-[2,3′]联吡啶及其合成方法 | |
| JP7377828B2 (ja) | ピリミジニルシクロペンタン化合物の調製方法 | |
| TW200916454A (en) | Process for controlled crystal size in 1,2-substituted 3,4-dioxo-1-cyclobutene compounds | |
| JP2024095561A5 (cg-RX-API-DMAC7.html) | ||
| CN107698574B (zh) | 一种高纯度阿瑞匹坦的精制制备工艺 | |
| JP5826371B2 (ja) | ペメトレキセド塩の製造方法 | |
| JP2023517729A5 (cg-RX-API-DMAC7.html) | ||
| CN1443178A (zh) | (r)-n-[5-甲基-8-(4-甲基哌嗪-1-基)-1,2,3,4-四氢-2-萘基]-4-吗啉代苯甲酰胺的新形态 | |
| AU2026200097A1 (en) | Salts of a isochromanyl compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof | |
| RU2019128576A (ru) | Сокристаллы замещенных глициновых соединений и их применение | |
| JP7858096B2 (ja) | tert-ブチル(S)-2-((2S,3R)-1-アミノ-3-ヒドロキシ-1-オキソブタン-2-イル)-1-オキソ-2,5-ジアザスピロ[3.4]オクタン-5-カルボキシレートの固体形態およびそれらを調製する方法 | |
| JP2004530660A5 (cg-RX-API-DMAC7.html) | ||
| JP2013520412A5 (cg-RX-API-DMAC7.html) | ||
| CN103864627B (zh) | 福莫特罗手性中间体的拆分方法 | |
| JP2022525169A5 (cg-RX-API-DMAC7.html) | ||
| CN103025705B (zh) | 4-甲基苯甲酸4-[2-二甲基胺基-1-(1-羟基环己基)乙基]苯酯盐酸盐的多晶型物、制备方法及其应用 | |
| TW201124139A (en) | Solid forms of 4-{(R)-(3-aminophenyl)[4-(4-fluorobenzyl)piperazin-1-yl]methyl}-n, n-diethylbenzamide, compositions thereof, and uses therewith | |
| JP7851426B2 (ja) | Hs378の結晶形とその製造方法 | |
| CN102030689A (zh) | 一种富马酸伊布利特的精制方法 | |
| CN112724081B (zh) | 一种异烟肼的制备方法 |